Dr. Armando E. Acevedo

Pediatrics
Brownsville Medical Center Inc
2400 NW 54th St, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Brownsville Medical Center Inc
2400 NW 54th St, 
Miami, FL 

Overview

Armando Acevedo is a Pediatrics provider practicing medicine in Miami, Florida.

His clinical expertise encompasses Asthma in Children, Obesity in Children, Viral Gastroenteritis, and Autism Spectrum Disorder.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials. Dr. Acevedo is currently accepting new patients.

Specialties

Pediatrics

Licenses

Specialist in FL

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 7 Less Insurance Carriers -

Locations

Brownsville Medical Center Inc
2400 NW 54th St, Miami, FL 33142

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Enrollment Status: Completed
Publish Date: August 20, 2026
Intervention Type: Biological
Study Phase: Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
Enrollment Status: Completed
Publish Date: January 17, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Terminated
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
Journal: The Journal of infectious diseases
Published: July 11, 2024
Similar Doctors
Expertise in
32
conditions
Dr. Kara M. Cavuoto
Ophthalmology | Pediatrics
Expertise in
32
conditions
Dr. Kara M. Cavuoto
Ophthalmology | Pediatrics
Referral may be required
900 Northwest 17th Street, 
Miami, FL 
 (2.8 miles away)
305-243-2020
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients

Kara Cavuoto is an Ophthalmologist and a Pediatrics provider practicing medicine in Miami, Florida. Dr. Cavuoto is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Strabismus, Brown Syndrome, Peters Anomaly, Iridectomy, and Vitrectomy. Dr. Cavuoto is currently accepting new patients.

Expertise in
7
conditions
Dr. Ofelia A. Alvarez
Hematology | Pediatrics
Expertise in
7
conditions
Dr. Ofelia A. Alvarez
Hematology | Pediatrics
Referral may be required
1475 Northwest 12th Avenue, 
Miami, FL 
 (2.8 miles away)
305-243-5302
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ofelia Alvarez is a Hematologist and a Pediatrics provider practicing medicine in Miami, Florida. Dr. Alvarez is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Alvarez is currently accepting new patients.

Expertise in
6
conditions
Dr. Hilda Capo
Ophthalmology | Pediatrics
Expertise in
6
conditions
Dr. Hilda Capo
Ophthalmology | Pediatrics
Referral may be required
900 Northwest 17th Street, 
Miami, FL 
 (2.8 miles away)
Experience:
44+ years
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients

Hilda Capo is an Ophthalmologist and a Pediatrics provider practicing medicine in Miami, Florida. She has been practicing medicine for over 44 years. Dr. Capo is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Strabismus, Brown Syndrome, Esotropia, Benign Essential Blepharospasm, and Tenotomy. Dr. Capo is currently accepting new patients.

Frequently Asked Questions about Dr. Armando E. Acevedo

How do I make an appointment with Dr. Armando E. Acevedo?

You can book an appointment with Dr. Armando E. Acevedo by calling their office at 305-633-9090. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Armando E. Acevedo a top-rated expert for Asthma in Children?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Armando E. Acevedo is classified as an Experienced expert for Asthma in Children, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Armando E. Acevedo specialize in?

While Dr. Armando E. Acevedo is a Pediatrics, they have specific expertise in Asthma in Children, Obesity in Children, and Viral Gastroenteritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Armando E. Acevedo participate in research or clinical trials?

Yes. Dr. Armando E. Acevedo has published 1 articles and abstracts on conditions like Asthma in Children. You can view a list of Dr. Armando E. Acevedo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Armando E. Acevedo accept my insurance?

Dr. Armando E. Acevedo accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 305-633-9090 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Acevedo's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile